AML-389 Phase 1/2 Study of SEL24/MEN1703, a First-in-Class Dual PIM/FLT3 Kinase Inhibitor, in Patients With IDH1/2-Mutated Acute Myeloid Leukemia: The DIAMOND-01 Trial
Abstract
Publication Date:
2022
Iris type:
1.5 Abstract in rivista
List of contributors:
Martinelli, Giovanni; Santoro, Armando; Gambacorti-Passerini, Carlo; Polo, Susana Vives; Solomon, Scott R.; Mukherjee, Sudipto; Lech-Maranda, Ewa; Levy, Moshe Yair; Wierzbowska, Agnieszka; Calbacho-Robles, María; Marconi, Giovanni; Giannini, Maria Benedetta; Cano, Isabel; Miñana, Laura Torres; Acuña-Cruz, Evelyn; Angelosanto, Noemi; Mughal, Tariq I.; Galleu, Antonio; Blotta, Simona; Ravandi, Farhad; Montesinos, Pau
Published in: